You Searched For "pfizer data security" and got 19 results
Sort By:
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate Ameri…
Alex Morrell
Pfizer and BioNTech says their vaccine data was 'unlawfully accessed' in a cyberattack on an EU regulator
U.S. drugmaker Pfizer and its German partner BioNTech said on Wednesday that regulation documents r…
US officials believe Russia launched a disinformation campaign against the Pfizer COVID-19 vaccine to boost the status of its own: Report
US intelligence officials believe this effort to undermine the Pfizer vaccine is a way to bolster t…
Yelena Dzhanova
US stocks trade mixed amid earnings rush and fresh economic data
The number of job openings in June dropped by more than expected, according to data from the Labor …
Jason Ma
The EU has secured access to up to 300 million extra Pfizer doses, following criticism for its slow COVID-19 vaccine rollout
"We have to raise the numbers of vaccinations rapidly," the European Commission's president, Ursula…
Grace Dean
The Pfizer and AstraZeneca COVID-19 vaccines are highly effective against the variant first found in India, but only if you get both doses, real-world data shows
Two shots of Pfizer's vaccine were 88% effective against the variant first identified in India, and…
Dr. Catherine Schuster-Bruce
In the Trump administration's efforts to secure coronavirus vaccines, two key bets turned out to be mistakes
By the time Pfizer's vaccine was authorized in the US, other countries had already bought up hundre…
Aria Bendix
Execs at Bank of America, Deloitte, and Pfizer say good governance makes meeting environmental and social goals possible
Companies with strong governance are more likely to meet their environmental and social goals, exec…
Tim Paradis
Pfizer's CEO says skipping the second dose of its coronavirus vaccine would be 'a very big mistake,' despite data suggesting partial protection from a single shot
The vaccine is about 95% effective at preventing COVID-19, as long as people get both doses.
Andrew Dunn
Booster shots protect against symptomatic Omicron infection for about 10 weeks, study finds — which could mean more doses for some in 2022
Experts said boosters should still provide protection against hospitalization and death from COVID-…
Dr. Catherine Schuster-Bruce
Vaccines are the best explanation for Omicron's mild symptoms in most people, new research suggests
Omicron seems to produce milder symptoms and fewer hospitalizations than Delta, likely because vacc…
Aria Bendix
A top healthcare investor reveals the new way she's backing startups
These are Insider's biggest healthcare stories for December 8.
Leah Rosenbaum
The FDA is preparing to authorize Pfizer's vaccine
These are the top stories written by Business Insider's healthcare team for the week ending Decembe…
Lydia Ramsey Pflanzer
FDA authorizes boosters of the Pfizer-BioNTech coronavirus vaccine for older adults and others at high risk from COVID-19
The hope is that booster shots will help protect those most at risk as the pandemic continues to ra…
Andrew Dunn
FDA releases documents outlining Pfizer's case for COVID-19 booster shots
A panel of independent experts are set to meet on Friday to debate whether people should get booste…
Andrew Dunn
Pfizer says its shot protection wanes after 6 months
These are Insider's biggest healthcare stories for July 29.
Lydia Ramsey Pflanzer
Pfizer's COVID-19 vaccine works very well against the Delta variant - but only after 2 doses
The study on 19,000 people in the UK found one Pfizer shot was about 36% effective against Delta, b…
Hilary Brueck
Bharat Biotech applies for emergency use approval for its COVID-19 vaccine Covaxin
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Coun…
PTI
India's latest unicorn is a data protection startup Druva – backed by Viking Global and Nexus Venture Partners
After this round, the total funding raised by the startup has gone beyond $328 million. It had…